What they were paid
Immunovant Director Compensation Table · all 5 fiscal years held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2026 | $60,233 | $246,058 | $78,559 | $0 | $384,850 |
| FY2025 | $65,000 | $346,429 | $106,107 | $0 | $517,536 |
| FY2024 | $63,800 | $184,088 | $185,909 | — | $433,797 |
| FY2023 | $63,800 | $105,084 | $118,736 | — | $287,620 |
| FY2021 | $59,740 | $733,047 | $730,034 | $45,750 | $1,568,571 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Immunovant, Inc. DEF 14A filed July 22, 2026, accession 0001764013-26-000092, and prior-year filings. Open the filing on EDGAR.
How this page was built: the Immunovant, Inc. filed document, accession 0001764013-26-000092. Every figure is read from that document and cited to the page and table it appears in. Filed July 22, 2026.
Get the Immunovant Board Governance Report
$384,850 Atul Pande, M.D, FY2026 total director compensation
$500
The free page is the headline figures. The board report is director pay, board composition and committee fees combined into the same kind of document.
Data as of July 22, 2026 · Source: Velarion Executive Compensation Database, deposited on Zenodo (doi:10.5281/zenodo.22283855).
How this board is paid
company policy · FY2026Immunovant pays directors a $50,000 cash retainer and $425,000 in 75% RSU / 25% Option.
Committees
FY2026 · as the proxy prints themNominating/Governance (Chair)
The rest of the Immunovant board
FY2026 · as the company reported each| Director | Role | FY2026 total |
|---|---|---|
| Andrew Fromkin | Independent Director | $397,351 |
| Douglas Hughes | Independent Director | $392,117 |
| Eric Venker, M.D., Pharm.D | Director | $2,597 |
| Frank M. Torti, M.D | Chair of the Board | $4,094,228 |
| Jacob Bauer | Independent Director | $862,075 |
| Robert Susman | Independent Director | $854,926 |
The full Immunovant compensation record
free company briefThis page is one director within Immunovant's record. The company brief lists every named executive and director, each linking to their own page.
Peer companies
named in the Immunovant proxy · each links to its own free briefOrder IMVT
Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.